Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.

Yuki TsukazakiHirokazu OginoYoshio OkanoSoji KakiuchiShoko HaradaYuko ToyodaYugo MatsumuraSeiya IchiharaTakeshi ImakuraRikako MatsumotoRyohiko OzakiEi OgawaYutaka MoritaAtsushi MitsuhashiYohei YabukiHiroto YonedaMasaki HanibuchiKayoko HaseEiji TakeuchiTakashi HakuYasuhiko Nishioka

Published in: International journal of clinical oncology (2024)

G-CSF has the potential to attenuate the efficacy of immunotherapy; therefore, the indication for G-CSF during chemo-immunotherapy should be carefully considered for ES-SCLC.

Keyphrases

small cell lung cancer
photodynamic therapy
cancer therapy
locally advanced
human health
combination therapy
peripheral blood
risk assessment
cerebrospinal fluid
brain metastases